Results 41 to 50 of about 36,916 (167)

Study of Intestinal Fatty Acid Binding Protein-2 in Cirrhotic Patients and its Relation to Chronic Use of Proton Pump Inhibitors in Decompensated Cirrhosis [PDF]

Afro-Egyptian Journal of Infectious and Endemic Diseases
Background and study aim: Proton pump inhibitors (PPIs) may contribute to the development of gut dysbiosis and increased risk of developing spontaneous bacterial peritonitis (SBP) and hepatic encephalopathy (HE) in patients with liver cirrhosis.
Rabab El Deeb, Hossam Abouelkheir, Akram Deghady, Eman Sallam, Marwa Elemam   +4 more
doaj   +1 more source

Critical Hypomagnesemia and Seizure Induced by Chronic Use of Proton Pump Inhibitors (PPIs)

Translation, 2019
Background: Chronic use of proton pump inhibitors (PPIs) may lead to severe hypomagnesemia, although it is a rare side effect. Hypomagnesemia related to PPIs use less reported compared to other side effects.
Gheith Yousif
doaj   +1 more source

Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study

Frontiers in Pharmacology, 2018
Background: The present study aimed to examine the odds of cholangiocarcinoma (CCA) in patients with proton pump inhibitors (PPIs) use.Methods: A nested case-control study design was employed using data obtained from Taiwan's National Health Insurance ...
Yen-Chun Peng, Yen-Chun Peng, Cheng-Li Lin, Cheng-Li Lin, Wan-Yun Hsu, Wai-Keung Chow, Show-Wu Lee, Hong-Zen Yeh, Hong-Zen Yeh, Chia-Chang Chen, Chia-Hung Kao, Chia-Hung Kao, Chia-Hung Kao   +12 more
doaj   +1 more source

Proton pump inhibitors stabilize the expression of PD‐L1 on cell membrane depending on the phosphorylation of GSK3β

Cancer Medicine
Background Preclinical and clinical evidence indicates that proton pump inhibitors (PPIs) may indirectly diminish the microbiome diversity, thereby reducing the effectiveness of immune checkpoint inhibitors (ICIs).
Long Gao, Yuan Liu, Jiaying Liu, Jiali Li, Haotian Li, Yanyan Liu, Fang Meng, Xiaohong Du, Yufeng Gao, Jiabin Li, F. Xiao‐Feng Qin   +10 more
doaj   +1 more source

Techniques for transferring host-pathogen protein interactions knowledge to new tasks

Frontiers in Microbiology, 2015
We consider the problem of building a model to predict protein-protein interactions (PPIs) between the bacterial species Salmonella Typhimurium and the plant host Arabidopsis thaliana which is a host-pathogen pair for which no known PPIs are available ...
Meghana eKshirsagar, Sylvia eSchleker, Sylvia eSchleker, Jaime eCarbonell, Judith eKlein-Seetharaman   +4 more
doaj   +1 more source

Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials

Children
This systematic review was conducted with the objective of understanding the efficacy and safety of proton pump inhibitors (PPIs) in the pediatric population.
Sara María Fernández-González, Ana Moreno-Álvarez, Alfonso Solar-Boga   +2 more
doaj   +1 more source

RAAP/PPI

Auteursrecht, 2021
Nationale implementatie van het recht op één billijke vergoeding voor mededeling aan het publiek van fonogram, te delen door uitvoerende kunstenaars en producenten (Art.  8, lid  2 richtlijn  2006/115 Verhuur- en leenrecht). Door de VS gemaakt voorbehoud op de verplichtingen uit het WPPT (WIPO Verdrag inzake uitvoeringen en fonogrammen 1996) leidt ...
openaire   +1 more source

Simultaneous Determination of Multiple Acid-Suppressing Drugs by UPLC-MS/MS Method and Application for Pharmacokinetics Study

Drug Design, Development and Therapy
Xiuqi Li,1,* Shupeng Liu,1,* Mengyang Yu,1 Wanlin Xi,1 Xiaofei Wu,1 Dan Liu,2 Aijing Liu,1 Hongyun Wang1 1Clinical Pharmacology Research Center, Peking Union Medical College Hospital, NMPA Key Laboratory for Clinical Research and Evaluation of ...
Li X, Liu S, Yu M, Xi W, Wu X, Liu D, Liu A, Wang H   +7 more
doaj  

Cardiovascular risk with long-term use of proton pump inhibitors: myth or reality. A review

Consilium Medicum
Proton pump inhibitors (PPIs) are the most effective drugs for treating acid-related diseases. In recent decades, the use of PPIs has increased exponentially.
Dmitry I. Trukhan, Sergej N. Filimonov
doaj   +1 more source

Analysis of inappropriate prophylactic use of proton pump inhibitors during the perioperative period: an observational study

Perioperative Medicine
Background The prevalence and characteristics of inappropriate use of proton pump inhibitors (PPIs) to prevent stress-related mucosal disease (SRMD) during the perioperative period and its associated factors are rarely reported.
Pengpeng Liu, Guangyao Li, Qian Wu, Mei Han, Chao Zhang   +4 more
doaj   +1 more source